Recipients of Oxford-AstraZeneca vaccine in Bangladesh are developing antibodies against Covid-19.
According to a study by Institute of Epidemiology Disease Control And Research and International Centre for Diarrhoeal Disease Research, Bangladesh-after the first month of the vaccination, 120 recipients developed 92 per cent antibodies. The percentage went up to 97 per cent after two months.
The presence of antibodies against Covid-19 has been found among all vaccine receivers irrespective of age.
